相关临床试验
126
39 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1994
进行中（未招募）
9
7.1%
已完成
29
23.0%
Enrolling By Invitation
3
2.4%
尚未招募
27
21.4%
招募中
34
27.0%
Unknown
24
19.1%
暂无批准数据
- Chinese researchers have developed "Bone-02," a medical adhesive inspired by oyster biology that can repair fractures and shattered bones in just two to three minutes. - The adhesive has been tested in over 150 patients and demonstrates a bonding force exceeding 400 pounds, with the ability to function effectively in blood-rich environments where traditional adhesives fail. - Unlike metal implants, Bone-02 is naturally absorbed by the body during healing, eliminating the need for secondary removal surgeries and potentially reducing infection risks. - Clinical trials show promising results with procedures that normally require steel plates and screws being completed in under three minutes using a single injection through a small incision.
- A randomized controlled trial is set to evaluate intracoronary tenecteplase (TNK) for preventing periprocedural myocardial infarction (PMI) in CAD patients undergoing PCI. - The study will enroll 864 CAD patients with evidence of eroded plaques confirmed by IVUS, randomizing them to either TNK or saline solution post-balloon angioplasty. - The primary outcome is the incidence of PCI-related MI, defined by elevated high-sensitivity cardiac troponin I levels, with secondary endpoints including MACE and angiographic flow. - Recruitment is planned across multiple centers in China from August 2024 to August 2025, aiming to reduce PMI incidence and improve outcomes after PCI.
